The past year brought tremendous legal changes to the cannabis industry...
The past year brought tremendous legal changes to the cannabis industry. While federal legalization failed to make significant progress, both New Jersey and New York legalized recreational cannabis for adult use and are working to establish regulations for the industry.
Given that it can be difficult to keep up with the quickly evolving cannabis legal landscape, below is a brief summary of several key developments that took place in 2021:
New Jersey Adult-Use Cannabis Market: On February 22, 2021, Gov. Phil Murphy signed the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act into law, legalizing and regulating cannabis use and possession for adults 21 years and older. In the following months, members of the New Jersey Cannabis Regulatory Commission (CRC) were appointed, and the CRC adopted its initial rules in August. On December 15, the CRC officially began to accept license applications for adult-use cannabis cultivation, manufacturing and testing laboratories. Almost 500 individuals and entities established accounts in the first four hours that the application portal was open.
New Jersey Medical Marijuana Program: The long-awaited expansion of New Jersey’s Medical Marijuana Program progressed over the past year. In October, the CRC approved 14 of the 2019 medicinal cannabis business applications that had been previously tied up in litigation. The approved applications included ten applications for cultivation permits and four applications for vertically-integrated permits. On December 7, the CRC voted to award provisional licenses to 30 additional retailers, 10 each in the central, northern and southern regions of the state. While existing medical cannabis alternative treatment centers (ATCs) will be the first to enter the recreational market, the CRC has not yet indicated a timeframe.
New York Adult-UseCannabis Market: On March 31, 2021, former New York Gov. Andrew Cuomo legalized adult-use cannabis by signing the New York Marihuana Regulation and Taxation Act (MRTA) into law. The legislation also expanded New York State’s existing medical marijuana and cannabinoid hemp programs and established the Office of Cannabis Management to oversee all three industries. The Office of Cannabis Management is currently working on regulations to govern New York’s legal adult-use cannabis industry.
Rise of Psychedelics: Although psychedelics, a class of natural and synthetic compounds that includes psilocybin, MDMA (3,4-methylenedioxymethamphetamine), ibogaine, and DMT (dimethyltryptamine), remain on Schedule 1 of the federal Controlled Substances Act (CSA), their promise as a recognized medical treatment continues to grow. In September, the Drug Enforcement Administration (DEA) proposed a massive increase in the production quotas of cannabis, psilocin, and psilocybin (“magic mushrooms”) for research purposes, with the intent of aiding in the development of new federally approved therapeutic medications. Efforts to reform state and regulations are also steadily gaining momentum, with Oregon becoming the first state in the country to establish a regulatory framework for the regulated, therapeutic use of psilocybin. On the federal level, Rep. Earl Blumenauer (D-OR), a vocal proponent of cannabis reform, has pledged to extend his reform efforts to psychedelics.
Federal Cannabis Legislation: Lawmakers of both parties proposed cannabis legalization bills in 2021. Most recently, Rep. Nancy Mace (R-SC) introduced the States Reform Act, which would decriminalize cannabis at the federal level while allowing states to establish their own regulations. This summer, Senate Majority Leader Chuck Schumer (D-NY) and Senators Cory Booker (D-NJ) and Ron Wyden (D-OR) released a discussion draft of the Cannabis Administration and Opportunity Act (CAOA). The Senators continue to solicit feedback from stakeholders and have yet to formally introduce the bill. While the full House also approved the Secure and Fair Enforcement (SAFE) Banking Act this fall as part of the National Defense Authorization Act (NDAA), the cannabis banking reform bill did not make it into the final Senate version.
Employment Law: Courts continue to expand protections for employees who legally use medical cannabis. In Hager v. M&K Construction, the Supreme Court of New Jersey ruled that medical cannabis is a reimbursable as reasonable or necessary treatment under the New Jersey Workers’ Compensation Act (WCA). The court further found that the New Jersey Jake Honig Compassionate Use Medical Marijuana Act (Compassionate Use Act) is not preempted and that the employer did not face a credible threat of federal criminal aiding-and-abetting or conspiracy liability.
As highlighted by the big cannabis law changes that took place in 2021, it is imperative to stay up-to-date on the latest legal developments and to consult with an experienced cannabis attorney who understands how to navigate the complex and rapidly evolving regulatory landscape.
If you have questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact Dan McKillop, or the Scarinci Hollenbeck attorney with whom you work, at 201-896-4100.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Supreme Court and Title VII: Implications for Reverse Discrimination
Earlier this month, the U.S. Supreme Court issued a decision in Ames v. Ohio Department of Youth Services vitiating the so-called “background circumstances” test required by half of federal circuit courts.1 The background circumstances test required majority group plaintiffs pleading discrimination under Title VII of the Civil Rights Act to meet a heightened pleading standard […]
Special purpose acquisition companies (better known as SPACs) appear to be making a comeback. SPAC offerings for 2025 have already nearly surpassed last year’s totals, with additional transactions in the pipeline. SPACs last experienced a boom between 2020–2021, with approximately 600 U.S. companies raising a record $163 billion in 2021. Notable companies that went public […]
Short Form Merger: Streamlining the Process for Businesses
Merging two companies is a complex legal and business transaction. A short form merger, in which an acquiring company merges with a subsidiary corporation, offers a more streamlined process that involves important corporate governance considerations. A short form merger, in which an acquiring company merges with a subsidiary corporation, offers a more streamlined process. However, […]
Tariff Response Options for Small Businesses Facing Financial Distress
The Trump Administration’s new tariffs are having an oversized impact on small businesses, which already tend to operate on razor thin margins. Many businesses have been forced to raise prices, find new suppliers, lay off staff, and delay growth plans. For businesses facing even more dire financial circumstances, there are additional tariff response options, including […]
Common Causes of Partnership Disputes and How to Resolve Them
Business partnerships, much like marriages, function exceptionally well when partners are aligned but can become challenging when disagreements arise. Partnership disputes often stem from conflicts over business strategy, financial management, and unclear role definitions among partners. Understanding Business Partnership Conflicts Partnership conflicts place significant stress on businesses, making proactive measures essential. Partnerships should establish detailed […]
Businesses Are Facing Financial Headwinds—A Practical Guide
*** The original article was featured on Bloomberg Tax, April 28, 2025 — As a tax attorney who spends much of my time helping people and companies who have large, unresolved issues with the IRS or one or more state tax departments, it often occurs to me that the best service that I can provide […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
